Andreas Schneider

Andreas Schneider is an accomplished executive in drug delivery systems with extensive experience in innovation, business development, and strategic management. Currently serving as a Governing Board Member of the Subcutaneous Drug Development & Delivery Consortium and Head of Innovation Delivery Systems at Ypsomed AG, Schneider leads a team focused on product and service innovation while managing cross-functional collaborations and budgets. Schneider's career includes roles in innovation and business development across various organizations, including advisory positions, academic lecturing, and research in collaboration with Novartis. Schneider holds a Ph.D. in Strategic Management and Innovation from ETH Zurich, complemented by additional executive education in strategy and leadership.